G-CSF Treatment in IVF

What is G-CSF and How Does it Work?

Successful embryo implantation is one of the most critical stages of in vitro fertilization (IVF). In some women, a thin endometrium may represent a significant obstacle to successful implantation, as the uterine lining does not provide the optimal environment required for embryo attachment and development.

G-CSF (Granulocyte Colony-Stimulating Factor) is a naturally occurring protein that stimulates the production of neutrophils, a type of white blood cell involved in the body’s immune defense. In the field of assisted reproduction, G-CSF has been used as a therapeutic approach to improve endometrial thickness and endometrial receptivity, referring to the ability of the uterine lining to support embryo implantation.

This treatment is mainly applied in women who present with thin endometrium, recurrent implantation failure, or potential immunological factors that may interfere with the implantation process. The goal of the therapy is to create a more favorable endometrial environment that can support successful embryo attachment and development. G-CSF may be administered either intrauterinely (directly into the uterus) or through a subcutaneous injection, depending on the patient’s medical history and the treatment protocol determined by the treating physician.

How It Acts on Endometrial Tissue

The effect of G-CSF on endometrial tissue is immediate and targeted. When injected intrauterinely or administered subcutaneously, G-CSF activates cellular mechanisms that enhance blood circulation, cellular regeneration, and a low-grade inflammatory response, which is considered beneficial for endometrial preparation. These processes contribute to the increase in thickness and functionality of the endometrium, facilitating embryo attachment and increasing the chances of successful implantation. The result is a more “welcoming” endometrium, capable of supporting pregnancy from the critical early stages.

When is G-CSF Infusion Recommended?

Treatment with G-CSF is not applied to all women undergoing IVF, but rather in specific cases where implantation has repeatedly failed or when the endometrium remains thinner than desired.

It represents a targeted option in situations where standard medical preparation is not sufficient to ensure an optimal environment for embryo implantation. The decision to administer G-CSF is made by the fertility specialist after a detailed evaluation of the patient’s medical history and ultrasound findings.

Recurrent Implantation Failure

One of the main indications for the use of G-CSF is recurrent implantation failure, despite the transfer of good-quality embryos. In such cases, the difficulty may not lie in the embryo itself but in the endometrial environment, which may not be sufficiently supportive for embryo attachment.

The use of G-CSF may help modify the endometrial microenvironment, potentially increasing the likelihood of successful implantation in subsequent treatment cycles. The addition of this therapy to the treatment protocol may significantly influence the course of fertility treatment for some patients.

Thin Endometrium (<7 mm)

Another important indication for the use of G-CSF is the presence of an endometrial thickness of less than 7 mm, even after hormonal or medical preparation. A thin endometrium is associated with lower implantation rates, as it may not provide the optimal conditions required for embryo implantation.

In such cases, intrauterine administration of G-CSF aims to improve endometrial vascularization and cellular density, which may contribute to an increase in both the thickness and functional quality of the endometrium. In some cases, the use of G-CSF has been associated with a measurable increase in endometrial thickness within a few days, facilitating the conditions necessary for embryo implantation.

Are you considering G-CSF treatment but unsure if it’s right for you?

Speak with a specialized Fertulity doctor and receive a personalized assessment based on your medical history.

Book your appointment today

G-CSF Administration Procedure

The administration of G-CSF is simple but requires proper preparation and medical supervision. It involves three basic stages: preparation, infusion, and post-procedure care. Each phase plays an important role in the safety and effectiveness of the treatment.

Before Treatment (Preparation)

The first step of the process involves a detailed evaluation by the treating physician. At this stage, information is collected regarding the patient’s medical history, current medications, and any previous IVF attempts.

The physician will assess whether G-CSF therapy is appropriate for your case, taking into consideration factors such as endometrial thickness, possible recurrent implantation failure, or other immunological factors that may affect implantation success. Proper preparation is an essential step to ensure both the safety of the treatment and the success of the procedure.

Embryo development in a lab dish, symbolizing advanced IVF techniques including G-CSF for improved endometrial receptivity.

During Treatment (Infusion)

Once the physician approves the treatment, G-CSF administration is performed. The method of administration depends on the specific indication.

In women with a thin endometrium, G-CSF may be administered intrauterinely, meaning directly into the uterine cavity, with the aim of improving endometrial thickness and receptivity. In other cases, where immunological factors associated with recurrent implantation failure are present, the physician may recommend subcutaneous administration of G-CSF.

The procedure is brief and carried out in a controlled medical environment. Most women do not experience pain or significant discomfort during the process.

Happy couple celebrates a positive pregnancy test, reflecting successful IVF results after intrauterine G-CSF infusion therapy.

After Treatment (Monitoring)

After the administration of G-CSF, the treatment continues with careful monitoring by the medical team. An ultrasound examination is usually performed to evaluate the response of the endometrium and to confirm that the desired thickness and appropriate structure for implantation have been achieved.

Depending on the body’s response, the physician may recommend repeating the treatment before embryo transfer to ensure the most favorable conditions for successful embryo implantation.

A newborn’s tiny hand gently holds an adult finger, symbolizing the successful IVF outcome after G-CSF endometrial treatment.

Benefits of G-CSF Treatment & Success Rates

G-CSF therapy is one of the most promising options for women who experience implantation difficulties during IVF. The greatest advantage of the treatment is the improvement of endometrial receptivity, which significantly increases the chances of implantation, especially in cases where previous attempts have failed. Additionally, the enhancement of endometrial thickness and quality provides a more stable substrate to support the embryo during the critical first days.

The application of the treatment is short, painless, and performed without the need for surgical intervention or general anesthesia. It is worth noting that G-CSF is often combined with other supportive therapies, such as PRP, for even greater effectiveness in difficult cases.

Although every body responds differently, studies show that in selected cases, G-CSF can significantly increase implantation rates. That is why it is recommended as a solution for women with a history of repeated failures or inadequate endometrial thickness. The key factor for success remains the personalized evaluation and proper application of the treatment by specialized medical staff.

Frequently Asked Questions About G-CSF Therapy

Is G-CSF treatment safe?

G-CSF treatment is considered safe when applied under the supervision of a specialized doctor. Most women do not experience side effects, and administration takes place in a controlled environment with strict protocols. Your doctor will assess in advance whether you meet the criteria for treatment based on your medical history and any potential drug interactions.

Does G-CSF infusion hurt?

No special preparation is required before the Intralipid infusion, although fasting for a few hours or following doctor’s instructions may be recommended. Allergy screening (e.g., for soy or egg) is also performed, and it’s best to avoid intense physical activity on the day of treatment. Your physician may request a blood test a few days prior to evaluate your general health status.

How quickly are the treatment results visible?

G-CSF’s effect on endometrial tissue is relatively immediate. Typically, within a few days, an increase in thickness and improvement in endometrial quality is observed. The doctor will reassess the findings via ultrasound before proceeding with embryo transfer.

Can the treatment be applied in every IVF cycle?

G-CSF is not applied routinely in every cycle. On the contrary, it is administered in a targeted manner in cases where there is a history of failed attempts or inadequate endometrial thickness. Its application is based on medical criteria and prior evaluation of your body’s response.

Our Doctors

In an era where fertility requires knowledge, care, and substantial guidance, FertUlity is not an impersonal clinic. It is two people who look you in the eye and accompany you step by step on the journey you dream of.

Dr. Maria Oikonomou Obstetrician – Gynecologist

See Full CV

Dr. Chrysostomos (Makis) Papadopoulos Obstetrician – Gynecologist, MD, PhDc, MIC I

See Full CV

The First Step Starts Now

You don’t need to have all the answers to begin.
All it takes is one first step, and a team that truly listens.

Book Your Consultation

FertulityThrough the Words of Parents

100% genuine, public Google reviews.
Because every fertility journey begins with honesty and trust.

Why choose FertUlity?

Because every fertility journey deserves the right support.

At FertUlity, we provide science-based fertility care with a human approach.
We support every path, from fertility assessment and preservation to modern assisted reproduction.